Global drug research may stagnate as funding lags
You must be signed in to read this analysis
In this article
- Innovation crisis?
- Consistent challenges
- Unaligned priorities
- Cost
- Competition
- Public funding
- Public-private partnerships
- Outlook
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.